Literature DB >> 11861299

Abnormally spliced beta-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay.

Sven Danckwardt1, Gabriele Neu-Yilik, Rolf Thermann, Ute Frede, Matthias W Hentze, Andreas E Kulozik.   

Abstract

Nonsense-mediated mRNA decay (NMD) represents a phylogenetically widely conserved splicing- and translation-dependent mechanism that eliminates transcripts with premature translation stop codons and suppresses the accumulation of C-terminally truncated peptides. Elimination of frameshifted transcripts that result from faulty splicing may be an important function of NMD. To test this hypothesis directly, this study used the IVS1 + 5 G>A thalassemia mutation of the human beta-globin gene as a model system. We generated beta-globin gene constructs with this mutation and an iron-responsive element in the 5' untranslated region, which allowed specific experimental activation and inactivation of translation and, hence, NMD of this transcript. Premessenger RNAs with IVS1 + 5 G>A were spliced at normal sites and cryptic sites, enabling a direct comparison of the effect of NMD on the accumulation of normal and frameshifted messenger RNAs. In transfected HeLa cells, the predominant frameshifted transcript was degraded under conditions of active NMD, whereas accumulation to high levels occurred under conditions of specifically disabled NMD, thereby indicating an important physiologic function of NMD in the control of the splicing process. An unexpected finding was that accumulation of a second aberrant transcript remained unaffected by NMD. The IVS1 + 5 G>A mutation thus revealed the presence of an unknown cis-acting determinant that influences the NMD sensitivity of a putative NMD substrate. It can therefore serve as a useful tool for defining the mechanisms that permit specific transcripts to circumvent the NMD pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861299     DOI: 10.1182/blood.v99.5.1811

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  Using 5'-PTMs to repair mutant beta-globin transcripts.

Authors:  Monique N Kierlin-Duncan; Bruce A Sullenger
Journal:  RNA       Date:  2007-06-07       Impact factor: 4.942

2.  Splicing remodels messenger ribonucleoprotein architecture via eIF4A3-dependent and -independent recruitment of exon junction complex components.

Authors:  Zuo Zhang; Adrian R Krainer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-02       Impact factor: 11.205

3.  Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decay.

Authors:  Manuela Platè; Stefano Duga; Luciano Baronciani; Silvia La Marca; Valentina Rubini; Pier Mannuccio Mannucci; Augusto B Federici; Rosanna Asselta
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

4.  Mechanism of escape from nonsense-mediated mRNA decay of human beta-globin transcripts with nonsense mutations in the first exon.

Authors:  Gabriele Neu-Yilik; Beate Amthor; Niels H Gehring; Sharif Bahri; Helena Paidassi; Matthias W Hentze; Andreas E Kulozik
Journal:  RNA       Date:  2011-03-09       Impact factor: 4.942

5.  Polyamine-regulated unproductive splicing and translation of spermidine/spermine N1-acetyltransferase.

Authors:  Mervi T Hyvönen; Anne Uimari; Tuomo A Keinänen; Sami Heikkinen; Riikka Pellinen; Tiina Wahlfors; Arja Korhonen; Ale Närvänen; Jarmo Wahlfors; Leena Alhonen; Juhani Jänne
Journal:  RNA       Date:  2006-06-29       Impact factor: 4.942

6.  Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182.

Authors:  Theophany Eystathioy; Edward K L Chan; Ken Takeuchi; Michael Mahler; LeeAnne M Luft; Douglas W Zochodne; Marvin J Fritzler
Journal:  J Mol Med (Berl)       Date:  2003-11-04       Impact factor: 4.599

7.  Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families.

Authors:  Zhi L Teo; Daniel J Park; Elena Provenzano; Catherine A Chatfield; Fabrice A Odefrey; Tu Nguyen-Dumont; James G Dowty; John L Hopper; Ingrid Winship; David E Goldgar; Melissa C Southey
Journal:  Breast Cancer Res       Date:  2013-02-28       Impact factor: 6.466

8.  Regulator of sex-limitation (Rsl) encodes a pair of KRAB zinc-finger genes that control sexually dimorphic liver gene expression.

Authors:  Christopher J Krebs; Leslie K Larkins; Ryan Price; Kathryn M Tullis; Raymond D Miller; Diane M Robins
Journal:  Genes Dev       Date:  2003-10-16       Impact factor: 11.361

9.  Computational definition of sequence motifs governing constitutive exon splicing.

Authors:  Xiang H-F Zhang; Lawrence A Chasin
Journal:  Genes Dev       Date:  2004-05-14       Impact factor: 11.361

10.  Three new PAX6 mutations including one causing an unusual ophthalmic phenotype associated with neurodevelopmental abnormalities.

Authors:  Anouk Dansault; Gabriel David; Claire Schwartz; Carolina Jaliffa; Véronique Vieira; Guillaume de la Houssaye; Karine Bigot; Françise Catin; Laurent Tattu; Catherine Chopin; Philippe Halimi; Olivier Roche; Nicole Van Regemorter; Francis Munier; Daniel Schorderet; Jean-Louis Dufier; Cécile Marsac; Daniel Ricquier; Maurice Menasche; Alfred Penfornis; Marc Abitbol
Journal:  Mol Vis       Date:  2007-04-02       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.